Developing in vitro expanded CD45RA⁺regulatory T cells as an adoptive cell therapy for Crohn's disease

Abstract

CD4(+)CD25(+)CD127(lo)CD45RA(+) Tregs may be the most appropriate population from which to expand Tregs for autologous Treg therapy for CD, paving the way for future clinical trials.